At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06998 GENOR-B
Trading 11-06 13:47:46
1.820
-0.050
-2.67%
High1.840Low1.770Vol196.50K
Open1.770D1 Closing1.870Amplitude3.74%
Mkt Cap946.40MTradable Cap946.40MTotal Shares520.00M
T/O354.41KT/O Rate0.04%Tradable Shares520.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Stock Track | Genor Biopharma Surges Nearly 88% on Merger Deal with Edding Group
Stock Track  ·  10-07
Stock Track | Genor Biopharma Surges Nearly 88% on Merger Deal with Edding Group
BRIEF-Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Reuters  ·  10-07
BRIEF-Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Genor Biopharma - on 13 Sept Co Entered Into Merger Agreement
THOMSON REUTERS  ·  10-07
Genor Biopharma - on 13 Sept Co Entered Into Merger Agreement
Genor Biopharma - Consideration of Proposed Merger Is to Be Wholly Settled by Way of Issuing Consideration Shares
THOMSON REUTERS  ·  10-07
Genor Biopharma - Consideration of Proposed Merger Is to Be Wholly Settled by Way of Issuing Consideration Shares
Genor Biopharma - Co Will Acquire Edding Group Company by Way of Merger
THOMSON REUTERS  ·  10-07
Genor Biopharma - Co Will Acquire Edding Group Company by Way of Merger
Genor Biopharma - Unit Genedd Will Be Merged With and Into Edding
THOMSON REUTERS  ·  10-07
Genor Biopharma - Unit Genedd Will Be Merged With and Into Edding
Trading Halt
THOMSON REUTERS  ·  09-13
Trading Halt
Genor Biopharma - Trading in Shares Halted With Effect From Friday
THOMSON REUTERS  ·  09-13
Genor Biopharma - Trading in Shares Halted With Effect From Friday
Genor Biopharma's Chairman Steps Down, CFO Appointed
MT Newswires Live  ·  09-13
Genor Biopharma's Chairman Steps Down, CFO Appointed
Genor Biopharma's Chairman Steps Down, CFO Appointed
MT Newswires Live  ·  09-13
Genor Biopharma's Chairman Steps Down, CFO Appointed
BRIEF-Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman
Reuters  ·  09-13
BRIEF-Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman
Jhbp Cy - Weng Chengyi Appointed as an Executive Director and Chief Financial Officer
THOMSON REUTERS  ·  09-13
Jhbp Cy - Weng Chengyi Appointed as an Executive Director and Chief Financial Officer
Jhbp Cy - Guo Feng Has Tendered His Resignation as Chairman and an Executive Director
THOMSON REUTERS  ·  09-13
Jhbp Cy - Guo Feng Has Tendered His Resignation as Chairman and an Executive Director
Genor Biopharma Holdings H1 Revenue RMB 14.5 Million
THOMSON REUTERS  ·  08-28
Genor Biopharma Holdings H1 Revenue RMB 14.5 Million
Genor Biopharma Signs License, Stock Purchase Deals with US-Based JV; Shares Jump 10%
MT Newswires Live  ·  08-05
Genor Biopharma Signs License, Stock Purchase Deals with US-Based JV; Shares Jump 10%
Genor Biopharma Signs License, Stock Purchase Deals with US-Based JV; Shares Jump 10%
MT Newswires Live  ·  08-05
Genor Biopharma Signs License, Stock Purchase Deals with US-Based JV; Shares Jump 10%
Stock Track | Genor Biopharma Soars on Licensing Deal for GB261
Stock Track  ·  08-05
Stock Track | Genor Biopharma Soars on Licensing Deal for GB261
BRIEF-Genor Biopharma Says On 2 Aug, Co Entered License Deal And Stock Purchase Deal With TRC 2004
Reuters  ·  08-05
BRIEF-Genor Biopharma Says On 2 Aug, Co Entered License Deal And Stock Purchase Deal With TRC 2004
Corrected- Genor Biopharma (Not Jhbp Cy) - on 2 August, Co Entered License Agreement and Stock Purchase Agreement With Trc 2004
THOMSON REUTERS  ·  08-05
Corrected- Genor Biopharma (Not Jhbp Cy) - on 2 August, Co Entered License Agreement and Stock Purchase Agreement With Trc 2004
Genor Biopharma - to Grant Trc 2004 Exclusive Worldwide License to Develop, Use, Manufacture, Commercialize and Otherwise Exploit Gb261
THOMSON REUTERS  ·  08-05
Genor Biopharma - to Grant Trc 2004 Exclusive Worldwide License to Develop, Use, Manufacture, Commercialize and Otherwise Exploit Gb261

Introduction

Company Name.
GENOR-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Genor Biopharma Holdings Ltd, formerly JHBP CY Holdings Ltd, is China-based company mainly engaged in the research and development of biopharmaceutical products. The Company focuses on the development and commercialization of oncology and autoimmune drugs. The Company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The Company mainly conducts its businesses in the China market.
Issue price:
--